Tomoyoshi Komiyama, Atsushi Ogura, Takatsugu Hirokawa, Miao Zhijing, Hiroshi Kamiguchi, Satomi Asai, Hayato Miyachi & Hiroyuki Kobayashi. (2016) Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3. International Journal of Molecular Sciences 18:1, pages 12.
Crossref
Gisoo Barnes, Ashutosh Pathak & Lee Schwartzberg. (2014) Pharmacoeconomics of Granulocyte Colony-Stimulating Factor: A Critical Review. Advances in Therapy 31:7, pages 683-695.
Crossref
Belinda R. Avalos & Edward A. Copelan. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
1347
1361
.
Nicole M. Kuderer. 2011. Hematopoietic Growth Factors in Oncology. Hematopoietic Growth Factors in Oncology
127
143
.
L. Marconato, U. Bonfanti, D. Stefanello, M. R. Lorenzo, G. Romanelli, S. Comazzi & E. Zini. (2008) Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?. Veterinary and Comparative Oncology 6:2, pages 80-89.
Crossref
F Ravandi. (2006) Role of cytokines in the treatment of acute leukemias: a review. Leukemia 20:4, pages 563-571.
Crossref
Farhad Ravandi & Partow Kebriaei. 2005. Cytokines and Cancer. Cytokines and Cancer
313
331
.
Merat Karbasian-Esfahani, Peter H. Wiernik, Yelena Novik, Elisabeth Paietta & Janice P. Dutcher. (2004) Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia. Cancer 101:6, pages 1414-1419.
Crossref
P. Quaglino, M.T. Fierro, G.L. Rossotto, P. Savoia & M.G. Bernengo. (2004) Treatment of advanced mycosis fungoides/Sezary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. British Journal of Dermatology 150:2, pages 327-336.
Crossref
Donatella AmicoAnna Maria BarbuiEugenio ErbaAlessandro RambaldiMartino IntronaJosée Golay. (2003) Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3. Blood 101:11, pages 4589-4597.
Crossref
R. B. Ewesuedo & M. J. Ratain. 2003. Oncologic Therapies. Oncologic Therapies
19
66
.
E. Robak, T. Robak, W. Biernat, J. Bartkowiak & E. Krykowski. (2002) Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia. British Journal of Dermatology 147:4, pages 775-780.
Crossref
Saskia A. Bouwhuis, Rokea A. el-Azhary, Marian T. McEvoy, Lawrence E. Gibson, Thomas M. Habermann, Thomas E. Witzig & Mark R. Pittelkow. (2002) Treatment of late-stage Sezary syndrome with 2-Chlorodeoxyadenosine. International Journal of Dermatology 41:6, pages 352-356.
Crossref
R. Bassan, T. Lerede, B. Chiodini, A. Rossi, M. Buelli & T. Barbui. 2001. Acute Leukemias VIII. Acute Leukemias VIII
438
445
.
R. Bassan, A. Z. S. Rohatiner, T. Lerede, M. Carter, E. Di Bona, E. Pogliani, G. Rossi, P. Fabris, S. Morandi, G. Lambertenghi-Deliliers, P. Casula, M. Vespignani, T. A. Lister & T. Barbui. 2001. Acute Leukemias VIII. Acute Leukemias VIII
402
413
.
R. Bassan, A. Rambaldi, T. Lerede, E. Di Bona, G. Rossi, E. Pogliani, G. Lambertenghi-Deliliers, P. Fabris, S. Morandi, M. Vespignani, T. Izzi, G. Corneo, P. Viero & T. Barbui. 2000. Transplantation in Hematology and Oncology. Transplantation in Hematology and Oncology
217
225
.
Gary H. Lyman & Lodovico Balducci. (1999) Update of the economic analyses of the use of the colony-stimulating factors. Current Opinion in Hematology 6:3, pages 145.
Crossref
Renato Bassan, Teresa Lerede, Eros Di Bona, Alessandro Rambaldi, Giuseppe Rossi, Enrico Pogliani, Alessandro Oriani, Anna D'Emilio, Teodosio Izzi, Giorgio Lambertenghi‐Deliliers, Gianmarco Corneo & Tiziano Barbui. (2001) Induction‐consolidation with an idarubicin‐containing regimen, unpurged marrow autograft, and post‐graft chemotherapy in adult acute lymphoblastic leukaemia. British Journal of Haematology 104:4, pages 755-762.
Crossref